Cart
sales@molnova.com
N-(2,6-dioxopiperidin-3-yl)-4-nitrophthalimide
CAS No. 55003-81-1
N-(2,6-dioxopiperidin-3-yl)-4-nitrophthalimide( 2-(2,6-dioxopiperidin-3-yl)-5-nitroisoindoline-1,3-dione )
Catalog No. M28630 CAS No. 55003-81-1
N-(2,6-dioxopiperidin-3-yl)-4-nitrophthalimide exhibit inhibition of CRBN.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 35 | In Stock |
|
| 25MG | 72 | In Stock |
|
| 50MG | 110 | In Stock |
|
| 100MG | 160 | In Stock |
|
| 200MG | 241 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-(2,6-dioxopiperidin-3-yl)-4-nitrophthalimide
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-(2,6-dioxopiperidin-3-yl)-4-nitrophthalimide exhibit inhibition of CRBN.
-
DescriptionN-(2,6-dioxopiperidin-3-yl)-4-nitrophthalimide exhibit inhibition of CRBN.
-
In Vitro——
-
In Vivo——
-
Synonyms2-(2,6-dioxopiperidin-3-yl)-5-nitroisoindoline-1,3-dione
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number55003-81-1
-
Formula Weight303.23
-
Molecular FormulaC13H9N3O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[O-][N+](c(cc1)cc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Howard I, et al. An expeditious route to the synthesis of kelampayosides A and B. Tetrahedron Lett. 1999;55(32): 9881-9898.
molnova catalog
related products
-
Gracillin
Gracillin can induce cell cycle arrest, oxidative stress, and apoptosis in HL60 cells, and has the potential to be developed as an antitumor agent.
-
Magnoloside F
Magnoloside F is a natural product found in the stem bark of Magnolia officinalis.
-
Antroquinonol
Antroquinonol is a ubiquinone derivative from Antrodia camphorata with anti-inflammatory and anticancer activities.Antroquinonol reduces oxidative stress and inhibits inflammation and sclerosis in mice with focal segmental glomerulosclerosis through enhancement of the Nrf2 signaling pathway.
